The calcium release-activated calcium channel Orai1 represents a crucial component in hypertrophic compensation and the development of dilated cardiomyopathy

Channels

Volumn 8, Issue 1, 2014, Pages 35-43

  Horton, Jaime S ^a   Buckley, Cadie L ^a,b   Alvarez, Ernest M ^a   Schorlemmer, Anita ^a,b   Stokes, Alexander J ^a,b,c  

^a UNIVERSITY OF HAWAII   (United States)

^b UNIVERSITY OF HAWAII   (United States)

^c CHAMINADE UNIVERSITY OF HONOLULU   (United States)

Author keywords

Apoptosis; Contraction coupling; CRACM1; Dilated cardiomyopathy; ICRAC; Orai1; Pressure overload

Indexed keywords

CALCIUM RELEASE ACTIVATED CALCIUM CHANNEL 1; CALCIUM; CALCIUM CHANNEL; ORAI1 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA CONSTRICTION; APOPTOSIS; ARTICLE; CELL SIZE; CELLULAR DISTRIBUTION; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; DOPPLER ECHOCARDIOGRAPHY; GRAVIMETRY; HEART FAILURE; HEART FUNCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE CELL; HEART MUSCLE FIBROSIS; HEART VENTRICLE HYPERTROPHY; HEART WEIGHT; MALE; MOUSE; NONHUMAN; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SURVIVAL; TRANSTHORACIC ECHOCARDIOGRAPHY; ANIMAL; C57BL MOUSE; CALCIUM SIGNALING; CARDIOMEGALY; DEFICIENCY; GENETICS; KNOCKOUT MOUSE; METABOLISM;

ANIMALS; CALCIUM; CALCIUM CHANNELS; CALCIUM SIGNALING; CARDIOMEGALY; CARDIOMYOPATHY, DILATED; HEART FAILURE; MALE; MICE, INBRED C57BL; MICE, KNOCKOUT;

EID: 84901445853     PISSN: 19336950     EISSN: 19336969     Source Type: Journal    
DOI: 10.4161/chan.26581     Document Type: Article

References (44)

1. Hou X, Pedi L, Diver MM, Long SB. Crystal structure of the calcium release-activated calcium channel Orai. Science 2012; 338:1308-13; PMID:23180775; http://dx.doi.org/10.1126/science.1228757
2. Prakriya M, Feske S, Gwack Y, Srikanth S, Rao A, Hogan PG. Orai1 is an essential pore subunit of the CRAC channel. Nature 2006; 443:230-3; PMID:16921383; http://dx.doi.org/10.1038/nature05122
3. Putney JW Jr. A model for receptor-regulated calcium entry. Cell Calcium 1986; 7:1-12; PMID:2420465; http://dx.doi.org/10.1016/0143-4160(86)90026-6
4. González-Cobos JC, Zhang X, Zhang W, Ruhle B, Motiani RK, Schindl R, Muik M, Spinelli AM, Bisaillon JM, Shinde AV, et al. Store-independent Orai1/3 channels activated by intracrine leukotriene C4: role in neointimal hyperplasia. Circ Res 2013; 112:1013-25; PMID:23349245; http://dx.doi.org/10. 1161/CIRCRESAHA.111.300220
5. Soboloff J, Madesh M, Gill DL. Sensing cellular stress through STIM proteins. Nat Chem Biol 2011; 7:488-92; PMID:21769090; http://dx.doi.org/10. 1038/nchembio.619
6. Lewis RS. Calcium signaling mechanisms in T lymphocytes. Annu Rev Immunol 2001; 19:497-521; PMID:11244045; http://dx.doi.org/10.1146/annurev.immunol.19. 1.497
7. Lewis RS. The molecular choreography of a store-operated calcium channel. Nature 2007; 446:284-7; PMID:17361175; http://dx.doi.org/10.1038/nature05637
8. Hoth M, Penner R. Calcium release-activated calcium current in rat mast cells. J Physiol 1993; 465:359-86; PMID:8229840
9. Hoth M, Penner R. Depletion of intracellular calcium stores activates a calcium current in mast cells. Nature 1992; 355:353-6; PMID:1309940; http://dx.doi.org/10.1038/355353a0
10. Hogan PG, Rao A. Dissecting ICRAC, a store-operated calcium current. Trends Biochem Sci 2007; 32:235-45; PMID:17434311; http://dx.doi.org/10.1016/j. tibs.2007.03.009
11. Hogan PG, Chen L, Nardone J, Rao A. Transcriptional regulation by calcium, calcineurin, and NFAT. Genes Dev 2003; 17:2205-32; PMID:12975316; http://dx.doi.org/10.1101/gad.1102703
12. Oh-hora M, Rao A. Calcium signaling in lymphocytes. Curr Opin Immunol 2008; 20:250-8; PMID:18515054; http://dx.doi.org/10.1016/j.coi.2008.04.004
13. Feske S. Calcium signalling in lymphocyte activation and disease. Nat Rev Immunol 2007; 7:690-702; PMID:17703229; http://dx.doi.org/10.1038/nri2152
14. Hara M, Ono K, Hwang MW, Iwasaki A, Okada M, Nakatani K, Sasayama S, Matsumori A. Evidence for a role of mast cells in the evolution to congestive heart failure. J Exp Med 2002; 195:375-81; PMID:11828013; http://dx.doi.org/10. 1084/jem.20002036
15. Dombrowicz D, Flamand V, Miyajima I, Ravetch JV, Galli SJ, Kinet JP. Absence of Fc epsilonRI alpha chain results in upregulation of Fc gammaRIII-dependent mast cell degranulation and anaphylaxis. Evidence of competition between Fc epsilonRI and Fc gammaRIII for limiting amounts of FcR beta and gamma chains. J Clin Invest 1997; 99:915-25; PMID:9062349; http://dx.doi.org/10.1172/JCI119256
16. Cimini M, Fazel S, Zhuo S, Xaymardan M, Fujii H, Weisel RD, Li RK. c-kit dysfunction impairs myocardial healing after infarction. Circulation 2007; 116(Suppl):I77-82; PMID:17846329; http://dx.doi.org/10.1161/CIRCULATIONAHA.107. 708107
17. Stiber JA, Rosenberg PB. The role of store-operated calcium influx in skeletal muscle signaling. Cell Calcium 2010; PMID:21176846
18. Kawasaki T, Ueyama T, Lange I, Feske S, Saito N. Protein kinase C-induced phosphorylation of Orai1 regulates the intracellular Ca2+ level via the store-operated Ca2+ channel. J Biol Chem 2010; 285:25720-30; PMID:20534587; http://dx.doi.org/10.1074/jbc.M109.022996
19. McCarl CA, Picard C, Khalil S, Kawasaki T, Röther J, Papolos A, Kutok J, Hivroz C, Ledeist F, Plogmann K, et al. ORAI1 deficiency and lack of store-operated Ca2+ entry cause immunodeficiency, myopathy, and ectodermal dysplasia. J Allergy Clin Immunol 2009; 124:1311-8, e7; PMID:20004786; http://dx.doi.org/10.1016/j.jaci.2009.10.007
20. Voelkers M, Salz M, Herzog N, Frank D, Dolatabadi N, Frey N, Gude N, Friedrich O, Koch WJ, Katus HA, et al. Orai1 and Stim1 regulate normal and hypertrophic growth in cardiomyocytes. J Mol Cell Cardiol 2010; 48:1329-34; PMID:20138887; http://dx.doi.org/10.1016/j.yjmcc.2010.01.020
21. Patten RD, Hall-Porter MR. Small animal models of heart failure: development of novel therapies, past and present. Circ Heart Fail 2009; 2:138-44; PMID:19808329; http://dx.doi.org/10.1161/CIRCHEARTFAILURE.108.839761
22. Rockman HA, Ono S, Ross RS, Jones LR, Karimi M, Bhargava V, Ross J Jr., Chien KR. Molecular and physiological alterations in murine ventricular dysfunction. Proc Natl Acad Sci U S A 1994; 91:2694-8; PMID:8146176; http://dx.doi.org/10.1073/pnas.91.7.2694
23. Lygate C. Surgical models of hypertrophy and heart failure: Myocardial infarction and transverse aortic constriction. Drug Discov Today Dis Models 2006; 3:283-90; http://dx.doi.org/10.1016/j.ddmod.2006.10.002
24. Berk BC, Fujiwara K, Lehoux S. ECM remodeling in hypertensive heart disease. J Clin Invest 2007; 117:568-75; PMID:17332884; http://dx.doi.org/10. 1172/JCI31044
25. Creemers EE, Pinto YM. Molecular mechanisms that control interstitial fibrosis in the pressure-overloaded heart. Cardiovasc Res 2011; 89:265-72; PMID:20880837; http://dx.doi.org/10.1093/cvr/cvq308
26. Bergman MR, Teerlink JR, Mahimkar R, Li L, Zhu BQ, Nguyen A, Dahi S, Karliner JS, Lovett DH. Cardiac matrix metalloproteinase-2 expression independently induces marked ventricular remodeling and systolic dysfunction. Am J Physiol Heart Circ Physiol 2007; 292:H1847-60; PMID:17158653; http://dx.doi.org/10.1152/ajpheart.00434.2006
27. Dobaczewski M, Chen W, Frangogiannis NG. Transforming growth factor (TGF)-β signaling in cardiac remodeling. J Mol Cell Cardiol 2011; 51:600-6; PMID:21059352; http://dx.doi.org/10.1016/j.yjmcc.2010.10.033
28. Barry SP, Davidson SM, Townsend PA. Molecular regulation of cardiac hypertrophy. Int J Biochem Cell Biol 2008; 40:2023-39; PMID:18407781; http://dx.doi.org/10.1016/j.biocel.2008.02.020
29. Thum T, Galuppo P, Wolf C, Fiedler J, Kneitz S, van Laake LW, Doevendans PA, Mummery CL, Borlak J, Haverich A, et al. MicroRNAs in the human heart: a clue to fetal gene reprogramming in heart failure. Circulation 2007; 116:258-67; PMID:17606841; http://dx.doi.org/10.1161/CIRCULATIONAHA.107.687947
30. Lai NC, Gao MH, Tang E, Tang R, Guo T, Dalton ND, Deng A, Tang T. Pressure overload-induced cardiac remodeling and dysfunction in the absence of interleukin 6 in mice. Lab Invest 2012; 92:1518-26; PMID:22825686; http://dx.doi.org/10.1038/labinvest.2012.97
31. Cahalan MD. STIMulating store-operated Ca(2+) entry. Nat Cell Biol 2009; 11:669-77; PMID:19488056; http://dx.doi.org/10.1038/ncb0609-669
32. Soboloff J, Rothberg BS, Madesh M, Gill DL. STIM proteins: dynamic calcium signal transducers. Nat Rev Mol Cell Biol 2012; 13:549-65; PMID:22914293; http://dx.doi.org/10.1038/nrm3414
33. Yazaki Y, Komuro I. Role of protein kinase system in the signal transduction of stretch-mediated myocyte growth. Basic Res Cardiol 1992; 87(Suppl 2):11-8; PMID:1338562
34. Cantley LC. The phosphoinositide 3-kinase pathway. Science 2002; 296:1655-7; PMID:12040186; http://dx.doi.org/10.1126/science.296.5573.1655
35. Condorelli G, Drusco A, Stassi G, Bellacosa A, Roncarati R, Iaccarino G, Russo MA, Gu Y, Dalton N, Chung C, et al. Akt induces enhanced myocardial contractility and cell size in vivo in transgenic mice. Proc Natl Acad Sci U S A 2002; 99:12333-8; PMID:12237475; http://dx.doi.org/10.1073/pnas.172376399
36. Heineke J, Molkentin JD. Regulation of cardiac hypertrophy by intracellular signalling pathways. Nat Rev Mol Cell Biol 2006; 7:589-600; PMID:16936699; http://dx.doi.org/10.1038/nrm1983
37. Olivetti G, Abbi R, Quaini F, Kajstura J, Cheng W, Nitahara JA, Quaini E, Di Loreto C, Beltrami CA, Krajewski S, et al. Apoptosis in the failing human heart. N Engl J Med 1997; 336:1131-41; PMID:9099657; http://dx.doi.org/10.1056/ NEJM199704173361603
38. Vig M, DeHaven WI, Bird GS, Billingsley JM, Wang H, Rao PE, Hutchings AB, Jouvin MH, Putney JW, Kinet JP. Defective mast cell effector functions in mice lacking the CRACM1 pore subunit of store-operated calcium release-activated calcium channels. Nat Immunol 2008; 9:89-96; PMID:18059270; http://dx.doi.org/ 10.1038/ni1550
39. Skarnes WC. Gene trapping methods for the identification and functional analysis of cell surface proteins in mice. Methods Enzymol 2000; 328:592-615; PMID:11075368; http://dx.doi.org/10.1016/S0076-6879(00)28420-6
40. McCarl CA, Khalil S, Ma J, Oh-hora M, Yamashita M, Roether J, Kawasaki T, Jairaman A, Sasaki Y, Prakriya M, et al. Store-operated Ca2+ entry through ORAI1 is critical for T cell-mediated autoimmunity and allograft rejection. J Immunol 2010; 185:5845-58; PMID:20956344; http://dx.doi.org/10.4049/jimmunol. 1001796
41. Bergmeier W, Oh-Hora M, McCarl CA, Roden RC, Bray PF, Feske S. R93W mutation in Orai1 causes impaired calcium influx in platelets. Blood 2009; 113:675-8; PMID:18952890; http://dx.doi.org/10.1182/blood-2008-08-174516
42. Horton JS, Buckley CL, Stokes AJ. Successful TRPV1 antagonist treatment for cardiac hypertrophy and heart failure in mice. Channels (Austin) 2013; 7:17-22; PMID:23221478; http://dx.doi.org/10.4161/chan.23006
43. Buckley CL, Stokes AJ. Corin-deficient W-sh mice poorly tolerate increased cardiac afterload. Regul Pept 2011; 172:44-50; PMID:21903139; http://dx.doi.org/10.1016/j.regpep.2011.08.006
44. Buckley CL, Stokes AJ. Mice lacking functional TRPV1 are protected from pressure overload cardiac hypertrophy. Channels (Austin) 2011; 5:367-74; PMID:21814047; http://dx.doi.org/10.4161/chan.5.4.17083